HEADER TRANSLOCASE 17-JAN-20 6XU2 TITLE HUMAN KARYOPHERIN RANBP5 (ISOFORM-3) COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMPORTIN-5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IMP5,IMPORTIN SUBUNIT BETA-3,KARYOPHERIN BETA-3,RAN-BINDING COMPND 5 PROTEIN 5,RANBP5; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ANTIPAIN; COMPND 9 CHAIN: B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IPO5, KPNB3, RANBP5; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: ACTINOMYCETIA; SOURCE 11 ORGANISM_TAXID: 1760 KEYWDS HUMAN KARYOPHERIN, PA-PB1 SUB-COMPLEX NUCLEAR IMPORT, INFLUENZA KEYWDS 2 POLYMERASE ASSEMBLY, HOST-PATHOGEN INTERACTION, TRANSLOCASE EXPDTA X-RAY DIFFRACTION AUTHOR C.SWALE,A.A.MCCARTHY,I.BERGER,C.BIENIOSSEK,B.DELMAS,R.W.H.RUIGROK, AUTHOR 2 T.CREPIN REVDAT 4 31-JAN-24 6XU2 1 REMARK REVDAT 3 07-DEC-22 6XU2 1 COMPND SOURCE REMARK DBREF REVDAT 3 2 1 SEQRES HET HETNAM FORMUL REVDAT 3 3 1 LINK SITE ATOM REVDAT 2 27-MAY-20 6XU2 1 JRNL REVDAT 1 22-APR-20 6XU2 0 JRNL AUTH C.SWALE,B.DA COSTA,L.SEDANO,F.GARZONI,A.A.MCCARTHY,I.BERGER, JRNL AUTH 2 C.BIENIOSSEK,R.W.H.RUIGROK,B.DELMAS,T.CREPIN JRNL TITL X-RAY STRUCTURE OF THE HUMAN KARYOPHERIN RANBP5, AN JRNL TITL 2 ESSENTIAL FACTOR FOR INFLUENZA POLYMERASE NUCLEAR JRNL TITL 3 TRAFFICKING. JRNL REF J.MOL.BIOL. V. 432 3353 2020 JRNL REFN ESSN 1089-8638 JRNL PMID 32222384 JRNL DOI 10.1016/J.JMB.2020.03.021 REMARK 2 REMARK 2 RESOLUTION. 2.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 96.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 81.0 REMARK 3 NUMBER OF REFLECTIONS : 35901 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1782 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.83 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.99 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 11.22 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2472 REMARK 3 BIN FREE R VALUE : 0.2454 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 32 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8518 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 137.6 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.70900 REMARK 3 B22 (A**2) : 1.90760 REMARK 3 B33 (A**2) : 0.80140 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.420 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.194 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.352 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.372 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.361 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8684 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 11781 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3026 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1496 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8684 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1145 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7264 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.80 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.84 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|21 - A|450 } REMARK 3 ORIGIN FOR THE GROUP (A): -2.1599 -25.3327 117.91 REMARK 3 T TENSOR REMARK 3 T11: 0.2261 T22: -0.304 REMARK 3 T33: -0.282 T12: 0.0762 REMARK 3 T13: 0.1105 T23: -0.1355 REMARK 3 L TENSOR REMARK 3 L11: 1.5991 L22: 3.0535 REMARK 3 L33: 0.7651 L12: -1.3237 REMARK 3 L13: 0.0719 L23: -1.1197 REMARK 3 S TENSOR REMARK 3 S11: -0.3027 S12: -0.3828 S13: 0.5442 REMARK 3 S21: -0.3828 S22: 0.192 S23: 0.1016 REMARK 3 S31: 0.5442 S32: 0.1016 S33: 0.1107 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|451 - A|800 } REMARK 3 ORIGIN FOR THE GROUP (A): -29.9481 -4.1699 132.245 REMARK 3 T TENSOR REMARK 3 T11: -0.1708 T22: -0.1221 REMARK 3 T33: -0.304 T12: -0.152 REMARK 3 T13: 0.107 T23: -0.0538 REMARK 3 L TENSOR REMARK 3 L11: 2.5663 L22: 2.2121 REMARK 3 L33: 4.4826 L12: 0.826 REMARK 3 L13: 0.108 L23: -0.2109 REMARK 3 S TENSOR REMARK 3 S11: 0.2006 S12: 0.13 S13: 0.1907 REMARK 3 S21: 0.13 S22: -0.0179 S23: -0.5442 REMARK 3 S31: 0.1907 S32: -0.5442 S33: -0.1828 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { A|801 - A|1115 } REMARK 3 ORIGIN FOR THE GROUP (A): -6.0694 25.8428 145.435 REMARK 3 T TENSOR REMARK 3 T11: -0.304 T22: 0.0009 REMARK 3 T33: 0.2193 T12: -0.109 REMARK 3 T13: 0.1027 T23: -0.152 REMARK 3 L TENSOR REMARK 3 L11: 1.6652 L22: 3.2187 REMARK 3 L33: 1.2688 L12: -0.654 REMARK 3 L13: -0.0573 L23: 1.0335 REMARK 3 S TENSOR REMARK 3 S11: 0.2308 S12: 0.2481 S13: -0.0286 REMARK 3 S21: 0.2481 S22: -0.0263 S23: -0.0408 REMARK 3 S31: -0.0286 S32: -0.0408 S33: -0.2045 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XU2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1292106270. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35901 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.830 REMARK 200 RESOLUTION RANGE LOW (A) : 48.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.0 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 20.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 1.12400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6XTE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 3350, 100 MM SODIUM DI REMARK 280 -HYDROGEN PHOSPHATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 48.54850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.70950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 63.12400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.70950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.54850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 63.12400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ANTIPAIN IS OLIGOPEPTIDE, A MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ANTIPAIN REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLU A 3 REMARK 465 ASP A 4 REMARK 465 GLN A 5 REMARK 465 VAL A 6 REMARK 465 GLY A 7 REMARK 465 LYS A 8 REMARK 465 LEU A 9 REMARK 465 GLU A 10 REMARK 465 ALA A 11 REMARK 465 THR A 12 REMARK 465 GLU A 13 REMARK 465 ASN A 14 REMARK 465 THR A 15 REMARK 465 ILE A 16 REMARK 465 SER A 17 REMARK 465 ALA A 18 REMARK 465 MET A 19 REMARK 465 ALA A 20 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 ASP A 348 REMARK 465 ASP A 349 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 62 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 138 CG CD1 CD2 REMARK 470 ILE A 139 CG1 CG2 CD1 REMARK 470 ASP A 140 CG OD1 OD2 REMARK 470 GLU A 141 CG CD OE1 OE2 REMARK 470 ASP A 142 CG OD1 OD2 REMARK 470 LYS A 230 CG CD CE NZ REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 GLU A 337 CG CD OE1 OE2 REMARK 470 ASP A 338 CG OD1 OD2 REMARK 470 LYS A 505 CG CD CE NZ REMARK 470 LYS A 514 CG CD CE NZ REMARK 470 LYS A 566 CG CD CE NZ REMARK 470 LYS A 588 CG CD CE NZ REMARK 470 LYS A 590 CG CD CE NZ REMARK 470 MET A 592 CG SD CE REMARK 470 GLN A 593 CG CD OE1 NE2 REMARK 470 ASP A 594 CG OD1 OD2 REMARK 470 SER A 596 OG REMARK 470 ASP A 597 CG OD1 OD2 REMARK 470 LYS A 604 CG CD CE NZ REMARK 470 ASP A 608 CG OD1 OD2 REMARK 470 PHE A 609 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN A 610 CG OD1 ND2 REMARK 470 ASP A 611 CG OD1 OD2 REMARK 470 MET A 612 CG SD CE REMARK 470 GLU A 613 CG CD OE1 OE2 REMARK 470 LYS A 635 CG CD CE NZ REMARK 470 LEU A 661 CG CD1 CD2 REMARK 470 GLN A 664 CG CD OE1 NE2 REMARK 470 MET A 666 CG SD CE REMARK 470 GLU A 667 CG CD OE1 OE2 REMARK 470 ASN A 668 CG OD1 ND2 REMARK 470 ASN A 935 CG OD1 ND2 REMARK 470 LYS A 981 CG CD CE NZ REMARK 470 LYS A1055 CG CD CE NZ REMARK 470 GLU A1067 CG CD OE1 OE2 REMARK 470 HIS A1071 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A1072 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL B 3 O - C - N ANGL. DEV. = -15.2 DEGREES REMARK 500 RGL B 4 C - N - CA ANGL. DEV. = 46.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 60 -75.02 -71.69 REMARK 500 PHE A 92 -44.55 -151.16 REMARK 500 SER A 101 2.98 -67.46 REMARK 500 GLU A 133 -52.44 79.71 REMARK 500 ASP A 140 13.37 -67.01 REMARK 500 GLU A 141 -71.40 -73.56 REMARK 500 GLN A 161 5.91 -65.65 REMARK 500 ASN A 182 50.63 -115.52 REMARK 500 HIS A 186 -49.86 -153.90 REMARK 500 TYR A 187 1.53 -68.32 REMARK 500 ASN A 222 43.39 -85.37 REMARK 500 HIS A 224 -23.92 71.63 REMARK 500 ASP A 252 49.03 -96.61 REMARK 500 HIS A 315 56.14 -106.20 REMARK 500 VAL A 331 40.06 -105.58 REMARK 500 ASP A 338 64.63 72.37 REMARK 500 ASN A 341 -63.30 -99.81 REMARK 500 TRP A 390 -54.51 70.54 REMARK 500 ASP A 470 38.82 -75.27 REMARK 500 LYS A 524 -12.38 -140.29 REMARK 500 GLU A 542 -123.96 48.67 REMARK 500 ALA A 563 73.59 -64.28 REMARK 500 MET A 612 65.94 -116.62 REMARK 500 ASP A 614 -139.43 -145.57 REMARK 500 ASP A 615 145.55 178.38 REMARK 500 ASP A 616 -40.96 100.51 REMARK 500 PRO A 617 -86.36 -91.95 REMARK 500 THR A 663 -152.90 57.28 REMARK 500 ASP A 665 34.72 -94.93 REMARK 500 ASP A 673 -45.60 74.81 REMARK 500 GLN A 683 -24.79 66.75 REMARK 500 LYS A 711 -122.46 56.61 REMARK 500 MET A 798 67.57 -151.33 REMARK 500 ASP A 800 109.97 73.39 REMARK 500 GLN A 834 48.85 70.17 REMARK 500 ASP A 837 50.06 -101.34 REMARK 500 LYS A 872 -153.83 62.78 REMARK 500 GLU A 873 -39.70 -39.64 REMARK 500 HIS A1021 2.76 -160.15 REMARK 500 HIS A1042 74.48 86.48 REMARK 500 ILE A1044 -48.18 75.15 REMARK 500 ASN A1049 31.48 70.72 REMARK 500 LYS A1070 -48.46 -29.70 REMARK 500 VAL B 3 -174.66 -6.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL B 3 RGL B 4 115.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 VAL B 3 22.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 1201 DBREF 6XU2 A 1 1115 UNP O00410 IPO5_HUMAN 1 1115 DBREF 6XU2 B 1 4 PDB 6XU2 6XU2 1 4 SEQRES 1 A 1115 MET PRO GLU ASP GLN VAL GLY LYS LEU GLU ALA THR GLU SEQRES 2 A 1115 ASN THR ILE SER ALA MET ALA ALA ALA ALA ALA GLU GLN SEQRES 3 A 1115 GLN GLN PHE TYR LEU LEU LEU GLY ASN LEU LEU SER PRO SEQRES 4 A 1115 ASP ASN VAL VAL ARG LYS GLN ALA GLU GLU THR TYR GLU SEQRES 5 A 1115 ASN ILE PRO GLY GLN SER LYS ILE THR PHE LEU LEU GLN SEQRES 6 A 1115 ALA ILE ARG ASN THR THR ALA ALA GLU GLU ALA ARG GLN SEQRES 7 A 1115 MET ALA ALA VAL LEU LEU ARG ARG LEU LEU SER SER ALA SEQRES 8 A 1115 PHE ASP GLU VAL TYR PRO ALA LEU PRO SER ASP VAL GLN SEQRES 9 A 1115 THR ALA ILE LYS SER GLU LEU LEU MET ILE ILE GLN MET SEQRES 10 A 1115 GLU THR GLN SER SER MET ARG LYS LYS VAL CYS ASP ILE SEQRES 11 A 1115 ALA ALA GLU LEU ALA ARG ASN LEU ILE ASP GLU ASP GLY SEQRES 12 A 1115 ASN ASN GLN TRP PRO GLU GLY LEU LYS PHE LEU PHE ASP SEQRES 13 A 1115 SER VAL SER SER GLN ASN VAL GLY LEU ARG GLU ALA ALA SEQRES 14 A 1115 LEU HIS ILE PHE TRP ASN PHE PRO GLY ILE PHE GLY ASN SEQRES 15 A 1115 GLN GLN GLN HIS TYR LEU ASP VAL ILE LYS ARG MET LEU SEQRES 16 A 1115 VAL GLN CYS MET GLN ASP GLN GLU HIS PRO SER ILE ARG SEQRES 17 A 1115 THR LEU SER ALA ARG ALA THR ALA ALA PHE ILE LEU ALA SEQRES 18 A 1115 ASN GLU HIS ASN VAL ALA LEU PHE LYS HIS PHE ALA ASP SEQRES 19 A 1115 LEU LEU PRO GLY PHE LEU GLN ALA VAL ASN ASP SER CYS SEQRES 20 A 1115 TYR GLN ASN ASP ASP SER VAL LEU LYS SER LEU VAL GLU SEQRES 21 A 1115 ILE ALA ASP THR VAL PRO LYS TYR LEU ARG PRO HIS LEU SEQRES 22 A 1115 GLU ALA THR LEU GLN LEU SER LEU LYS LEU CYS GLY ASP SEQRES 23 A 1115 THR SER LEU ASN ASN MET GLN ARG GLN LEU ALA LEU GLU SEQRES 24 A 1115 VAL ILE VAL THR LEU SER GLU THR ALA ALA ALA MET LEU SEQRES 25 A 1115 ARG LYS HIS THR ASN ILE VAL ALA GLN THR ILE PRO GLN SEQRES 26 A 1115 MET LEU ALA MET MET VAL ASP LEU GLU GLU ASP GLU ASP SEQRES 27 A 1115 TRP ALA ASN ALA ASP GLU LEU GLU ASP ASP ASP PHE ASP SEQRES 28 A 1115 SER ASN ALA VAL ALA GLY GLU SER ALA LEU ASP ARG MET SEQRES 29 A 1115 ALA CYS GLY LEU GLY GLY LYS LEU VAL LEU PRO MET ILE SEQRES 30 A 1115 LYS GLU HIS ILE MET GLN MET LEU GLN ASN PRO ASP TRP SEQRES 31 A 1115 LYS TYR ARG HIS ALA GLY LEU MET ALA LEU SER ALA ILE SEQRES 32 A 1115 GLY GLU GLY CYS HIS GLN GLN MET GLU GLY ILE LEU ASN SEQRES 33 A 1115 GLU ILE VAL ASN PHE VAL LEU LEU PHE LEU GLN ASP PRO SEQRES 34 A 1115 HIS PRO ARG VAL ARG TYR ALA ALA CYS ASN ALA VAL GLY SEQRES 35 A 1115 GLN MET ALA THR ASP PHE ALA PRO GLY PHE GLN LYS LYS SEQRES 36 A 1115 PHE HIS GLU LYS VAL ILE ALA ALA LEU LEU GLN THR MET SEQRES 37 A 1115 GLU ASP GLN GLY ASN GLN ARG VAL GLN ALA HIS ALA ALA SEQRES 38 A 1115 ALA ALA LEU ILE ASN PHE THR GLU ASP CYS PRO LYS SER SEQRES 39 A 1115 LEU LEU ILE PRO TYR LEU ASP ASN LEU VAL LYS HIS LEU SEQRES 40 A 1115 HIS SER ILE MET VAL LEU LYS LEU GLN GLU LEU ILE GLN SEQRES 41 A 1115 LYS GLY THR LYS LEU VAL LEU GLU GLN VAL VAL THR SER SEQRES 42 A 1115 ILE ALA SER VAL ALA ASP THR ALA GLU GLU LYS PHE VAL SEQRES 43 A 1115 PRO TYR TYR ASP LEU PHE MET PRO SER LEU LYS HIS ILE SEQRES 44 A 1115 VAL GLU ASN ALA VAL GLN LYS GLU LEU ARG LEU LEU ARG SEQRES 45 A 1115 GLY LYS THR ILE GLU CYS ILE SER LEU ILE GLY LEU ALA SEQRES 46 A 1115 VAL GLY LYS GLU LYS PHE MET GLN ASP ALA SER ASP VAL SEQRES 47 A 1115 MET GLN LEU LEU LEU LYS THR GLN THR ASP PHE ASN ASP SEQRES 48 A 1115 MET GLU ASP ASP ASP PRO GLN ILE SER TYR MET ILE SER SEQRES 49 A 1115 ALA TRP ALA ARG MET CYS LYS ILE LEU GLY LYS GLU PHE SEQRES 50 A 1115 GLN GLN TYR LEU PRO VAL VAL MET GLY PRO LEU MET LYS SEQRES 51 A 1115 THR ALA SER ILE LYS PRO GLU VAL ALA LEU LEU ASP THR SEQRES 52 A 1115 GLN ASP MET GLU ASN MET SER ASP ASP ASP GLY TRP GLU SEQRES 53 A 1115 PHE VAL ASN LEU GLY ASP GLN GLN SER PHE GLY ILE LYS SEQRES 54 A 1115 THR ALA GLY LEU GLU GLU LYS SER THR ALA CYS GLN MET SEQRES 55 A 1115 LEU VAL CYS TYR ALA LYS GLU LEU LYS GLU GLY PHE VAL SEQRES 56 A 1115 GLU TYR THR GLU GLN VAL VAL LYS LEU MET VAL PRO LEU SEQRES 57 A 1115 LEU LYS PHE TYR PHE HIS ASP GLY VAL ARG VAL ALA ALA SEQRES 58 A 1115 ALA GLU SER MET PRO LEU LEU LEU GLU CYS ALA ARG VAL SEQRES 59 A 1115 ARG GLY PRO GLU TYR LEU THR GLN MET TRP HIS PHE MET SEQRES 60 A 1115 CYS ASP ALA LEU ILE LYS ALA ILE GLY THR GLU PRO ASP SEQRES 61 A 1115 SER ASP VAL LEU SER GLU ILE MET HIS SER PHE ALA LYS SEQRES 62 A 1115 CYS ILE GLU VAL MET GLY ASP GLY CYS LEU ASN ASN GLU SEQRES 63 A 1115 HIS PHE GLU GLU LEU GLY GLY ILE LEU LYS ALA LYS LEU SEQRES 64 A 1115 GLU GLU HIS PHE LYS ASN GLN GLU LEU ARG GLN VAL LYS SEQRES 65 A 1115 ARG GLN ASP GLU ASP TYR ASP GLU GLN VAL GLU GLU SER SEQRES 66 A 1115 LEU GLN ASP GLU ASP ASP ASN ASP VAL TYR ILE LEU THR SEQRES 67 A 1115 LYS VAL SER ASP ILE LEU HIS SER ILE PHE SER SER TYR SEQRES 68 A 1115 LYS GLU LYS VAL LEU PRO TRP PHE GLU GLN LEU LEU PRO SEQRES 69 A 1115 LEU ILE VAL ASN LEU ILE CYS PRO HIS ARG PRO TRP PRO SEQRES 70 A 1115 ASP ARG GLN TRP GLY LEU CYS ILE PHE ASP ASP VAL ILE SEQRES 71 A 1115 GLU HIS CYS SER PRO ALA SER PHE LYS TYR ALA GLU TYR SEQRES 72 A 1115 PHE LEU ARG PRO MET LEU GLN TYR VAL CYS ASP ASN SER SEQRES 73 A 1115 PRO GLU VAL ARG GLN ALA ALA ALA TYR GLY LEU GLY VAL SEQRES 74 A 1115 MET ALA GLN TYR GLY GLY ASP ASN TYR ARG PRO PHE CYS SEQRES 75 A 1115 THR GLU ALA LEU PRO LEU LEU VAL ARG VAL ILE GLN SER SEQRES 76 A 1115 ALA ASP SER LYS THR LYS GLU ASN VAL ASN ALA THR GLU SEQRES 77 A 1115 ASN CYS ILE SER ALA VAL GLY LYS ILE MET LYS PHE LYS SEQRES 78 A 1115 PRO ASP CYS VAL ASN VAL GLU GLU VAL LEU PRO HIS TRP SEQRES 79 A 1115 LEU SER TRP LEU PRO LEU HIS GLU ASP LYS GLU GLU ALA SEQRES 80 A 1115 VAL GLN THR PHE ASN TYR LEU CYS ASP LEU ILE GLU SER SEQRES 81 A 1115 ASN HIS PRO ILE VAL LEU GLY PRO ASN ASN THR ASN LEU SEQRES 82 A 1115 PRO LYS ILE PHE SER ILE ILE ALA GLU GLY GLU MET HIS SEQRES 83 A 1115 GLU ALA ILE LYS HIS GLU ASP PRO CYS ALA LYS ARG LEU SEQRES 84 A 1115 ALA ASN VAL VAL ARG GLN VAL GLN THR SER GLY GLY LEU SEQRES 85 A 1115 TRP THR GLU CYS ILE ALA GLN LEU SER PRO GLU GLN GLN SEQRES 86 A 1115 ALA ALA ILE GLN GLU LEU LEU ASN SER ALA SEQRES 1 B 4 FC0 ARG VAL RGL HET FC0 B 1 13 HET RGL B 4 11 HET NI A1201 1 HETNAM FC0 N-CARBOXY-L-PHENYLALANINE HETNAM RGL ARGINAL HETNAM NI NICKEL (II) ION FORMUL 2 FC0 C10 H11 N O4 FORMUL 2 RGL C6 H15 N4 O 1+ FORMUL 3 NI NI 2+ FORMUL 4 HOH *14(H2 O) HELIX 1 AA1 ALA A 23 LEU A 36 1 14 HELIX 2 AA2 ASP A 40 ASN A 53 1 14 HELIX 3 AA3 SER A 58 LEU A 64 1 7 HELIX 4 AA4 LEU A 64 ASN A 69 1 6 HELIX 5 AA5 ALA A 73 SER A 90 1 18 HELIX 6 AA6 PRO A 100 GLU A 118 1 19 HELIX 7 AA7 GLN A 120 ASP A 140 1 21 HELIX 8 AA8 TRP A 147 SER A 160 1 14 HELIX 9 AA9 ASN A 162 PHE A 176 1 15 HELIX 10 AB1 HIS A 186 GLN A 200 1 15 HELIX 11 AB2 HIS A 204 ASN A 222 1 19 HELIX 12 AB3 ASN A 225 PHE A 232 1 8 HELIX 13 AB4 LEU A 235 CYS A 247 1 13 HELIX 14 AB5 TYR A 248 ASN A 250 5 3 HELIX 15 AB6 SER A 253 VAL A 265 1 13 HELIX 16 AB7 PRO A 266 PRO A 271 5 6 HELIX 17 AB8 HIS A 272 ASP A 286 1 15 HELIX 18 AB9 ASN A 290 ALA A 308 1 19 HELIX 19 AC1 ALA A 308 ARG A 313 1 6 HELIX 20 AC2 HIS A 315 VAL A 331 1 17 HELIX 21 AC3 SER A 352 GLY A 369 1 18 HELIX 22 AC4 GLY A 369 GLN A 386 1 18 HELIX 23 AC5 TRP A 390 GLU A 412 1 23 HELIX 24 AC6 ILE A 414 LEU A 423 1 10 HELIX 25 AC7 LEU A 424 ASP A 428 5 5 HELIX 26 AC8 HIS A 430 PHE A 448 1 19 HELIX 27 AC9 PRO A 450 ASP A 470 1 21 HELIX 28 AD1 ASN A 473 ASP A 490 1 18 HELIX 29 AD2 PRO A 492 ILE A 497 1 6 HELIX 30 AD3 TYR A 499 LYS A 521 1 23 HELIX 31 AD4 LYS A 524 GLU A 542 1 19 HELIX 32 AD5 GLU A 543 PRO A 547 5 5 HELIX 33 AD6 TYR A 548 ALA A 563 1 16 HELIX 34 AD7 LEU A 568 MET A 592 1 25 HELIX 35 AD8 ASP A 594 ASP A 611 1 18 HELIX 36 AD9 PRO A 617 GLY A 634 1 18 HELIX 37 AE1 LYS A 635 GLN A 639 5 5 HELIX 38 AE2 TYR A 640 ALA A 652 1 13 HELIX 39 AE3 GLY A 692 LYS A 711 1 20 HELIX 40 AE4 PHE A 714 LEU A 729 1 16 HELIX 41 AE5 HIS A 734 ARG A 753 1 20 HELIX 42 AE6 GLY A 756 GLU A 778 1 23 HELIX 43 AE7 ASP A 780 MET A 798 1 19 HELIX 44 AE8 ASN A 804 ARG A 833 1 30 HELIX 45 AE9 ASP A 839 LYS A 872 1 34 HELIX 46 AF1 VAL A 875 GLU A 880 1 6 HELIX 47 AF2 LEU A 882 ILE A 890 1 9 HELIX 48 AF3 PRO A 895 CYS A 913 1 19 HELIX 49 AF4 PRO A 915 LYS A 919 5 5 HELIX 50 AF5 TYR A 920 VAL A 932 1 13 HELIX 51 AF6 SER A 936 TYR A 953 1 18 HELIX 52 AF7 GLY A 955 ASN A 957 5 3 HELIX 53 AF8 TYR A 958 SER A 975 1 18 HELIX 54 AF9 ASN A 983 LYS A 1001 1 19 HELIX 55 AG1 ASN A 1006 LEU A 1018 1 13 HELIX 56 AG2 ASP A 1023 SER A 1040 1 18 HELIX 57 AG3 GLY A 1047 THR A 1051 5 5 HELIX 58 AG4 ASN A 1052 ALA A 1061 1 10 HELIX 59 AG5 ASP A 1073 GLN A 1085 1 13 HELIX 60 AG6 VAL A 1086 THR A 1088 5 3 HELIX 61 AG7 SER A 1089 GLN A 1099 1 11 HELIX 62 AG8 SER A 1101 ALA A 1115 1 15 SHEET 1 AA1 3 VAL A 658 ALA A 659 0 SHEET 2 AA1 3 PHE A 686 LYS A 689 -1 O GLY A 687 N ALA A 659 SHEET 3 AA1 3 TRP A 675 VAL A 678 -1 N VAL A 678 O PHE A 686 LINK C1 FC0 B 1 N ARG B 2 1555 1555 1.45 LINK C VAL B 3 N RGL B 4 1555 1555 1.37 CISPEP 1 ALA A 449 PRO A 450 0 -4.93 CISPEP 2 SER A 914 PRO A 915 0 0.64 CISPEP 3 LEU A 1018 PRO A 1019 0 5.98 CISPEP 4 GLU A 1062 GLY A 1063 0 -1.46 SITE 1 AC1 1 HIS A 765 CRYST1 97.097 126.248 149.419 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010299 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007921 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006693 0.00000